Changes in the Immunomodulatory Properties of Adipose Stromal Cells Due to Hemarthrosis After Knee Injury
CASH
1 other identifier
observational
20
1 country
1
Brief Summary
The goal of this observational study is to gain insight in the natural course of pro-inflammatory factors and hemarthrosis in patients older than 18 with a recent knee trauma. The main question\[s\] it aims to answer are:
- What is the natural course of pro-inflammatory factors and hemarthrosis in knee trauma?
- What are the effects of inflammation and hemarthrosis on the anti-inflammatory potential of ASC's in order to better determine eligible patients and circumstances for ASC's therapy? Participants will:
- undergo blood withdrawal
- undergo knee arthrocentesis for synovial fluid sample collection
- physical examination
- fill out a questionnaire on knee complaints
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 5, 2022
CompletedFirst Submitted
Initial submission to the registry
December 13, 2022
CompletedFirst Posted
Study publicly available on registry
January 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedJanuary 18, 2023
December 1, 2022
12 months
December 13, 2022
January 17, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Synovial fluid analysis
Analysis of changes in pro-inflammatory factors, erythrocytes (as measurement for hemarthrosis)
Samples are taken at week 1, week 2, week 4, week 6 and week 8 after trauma
Secondary Outcomes (4)
co-culture of synovial fluid with adipose stromal cells
samples are taken at week 1, week 2, week 4, week 6 and week 8 after trauma
MRI-imaging
At inclusion and 1 year after trauma
Physical examination
Physical examination at week 1, week 2, week 4, week 6 and week 8 after trauma
Knee Injury and Osteoarthritis Outcome Score (KOOS) questionnaire
Questionnaires are taken at week 1, week 2, week 4, week 6 and week 8 after trauma
Study Arms (2)
Patients with hemarthrosis
10 patients that sustained a knee trauma and have hemarthrosis during knee arthrocentesis (red color of the synovial fluid)
Patients without hemarthrosis
10 patients that sustained a knee trauma and do not have hemarthrosis during knee arthrocentesis (yellow color of the synovial fluid)
Interventions
arthrocentesis of the knee joint to gather a synovial fluid sample
Peripheral venipuncture to gather a blood sample
Physical examination of the injured knee
KOOS questionnaire of the injured knee
Eligibility Criteria
Adult patients who are presented at the emergency department of the CWZ hospital because of a recent distortion of the knee.
You may qualify if:
- Recently suffered an injury of the index knee (rotational or hyperextension)
- A swollen joint
- Inability to mobilise
You may not qualify if:
- Patients with an active inflammatory or infectious comorbid disease (including rheumatic diseases)
- Patients using systemic immunosuppressant medication
- Patients with a contra-indication for undergoing a MRI-scan (non-compatible implants or claustrophobia for example)
- Patients with knee prosthesis
- Patients with coagulation disorders
- Patients with a history of a cruciate ligament or meniscal injury of the index knee
- Patients with a tibiofemoral fracture of the index knee due to current distortion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Radboud umc
Nijmegen, Gelderland, 6525GA, Netherlands
Related Publications (10)
Riordan EA, Little C, Hunter D. Pathogenesis of post-traumatic OA with a view to intervention. Best Pract Res Clin Rheumatol. 2014 Feb;28(1):17-30. doi: 10.1016/j.berh.2014.02.001.
PMID: 24792943BACKGROUNDLohmander LS, Englund PM, Dahl LL, Roos EM. The long-term consequence of anterior cruciate ligament and meniscus injuries: osteoarthritis. Am J Sports Med. 2007 Oct;35(10):1756-69. doi: 10.1177/0363546507307396. Epub 2007 Aug 29.
PMID: 17761605BACKGROUNDLuc B, Gribble PA, Pietrosimone BG. Osteoarthritis prevalence following anterior cruciate ligament reconstruction: a systematic review and numbers-needed-to-treat analysis. J Athl Train. 2014 Nov-Dec;49(6):806-19. doi: 10.4085/1062-6050-49.3.35.
PMID: 25232663BACKGROUNDAyral X, Pickering EH, Woodworth TG, Mackillop N, Dougados M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis -- results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage. 2005 May;13(5):361-7. doi: 10.1016/j.joca.2005.01.005.
PMID: 15882559BACKGROUNDPulles AE, Mastbergen SC, Schutgens RE, Lafeber FP, van Vulpen LF. Pathophysiology of hemophilic arthropathy and potential targets for therapy. Pharmacol Res. 2017 Jan;115:192-199. doi: 10.1016/j.phrs.2016.11.032. Epub 2016 Nov 24.
PMID: 27890816BACKGROUNDGupte C, St Mart JP. The acute swollen knee: diagnosis and management. J R Soc Med. 2013 Jul;106(7):259-68. doi: 10.1177/0141076813482831.
PMID: 23821708BACKGROUNDWang Y, Shimmin A, Ghosh P, Marks P, Linklater J, Connell D, Hall S, Skerrett D, Itescu S, Cicuttini FM. Safety, tolerability, clinical, and joint structural outcomes of a single intra-articular injection of allogeneic mesenchymal precursor cells in patients following anterior cruciate ligament reconstruction: a controlled double-blind randomised trial. Arthritis Res Ther. 2017 Aug 2;19(1):180. doi: 10.1186/s13075-017-1391-0.
PMID: 28768528BACKGROUNDter Huurne M, Schelbergen R, Blattes R, Blom A, de Munter W, Grevers LC, Jeanson J, Noel D, Casteilla L, Jorgensen C, van den Berg W, van Lent PL. Antiinflammatory and chondroprotective effects of intraarticular injection of adipose-derived stem cells in experimental osteoarthritis. Arthritis Rheum. 2012 Nov;64(11):3604-13. doi: 10.1002/art.34626.
PMID: 22961401BACKGROUNDSchelbergen RF, van Dalen S, ter Huurne M, Roth J, Vogl T, Noel D, Jorgensen C, van den Berg WB, van de Loo FA, Blom AB, van Lent PL. Treatment efficacy of adipose-derived stem cells in experimental osteoarthritis is driven by high synovial activation and reflected by S100A8/A9 serum levels. Osteoarthritis Cartilage. 2014 Aug;22(8):1158-66. doi: 10.1016/j.joca.2014.05.022. Epub 2014 Jun 10.
PMID: 24928317BACKGROUNDPers YM, Rackwitz L, Ferreira R, Pullig O, Delfour C, Barry F, Sensebe L, Casteilla L, Fleury S, Bourin P, Noel D, Canovas F, Cyteval C, Lisignoli G, Schrauth J, Haddad D, Domergue S, Noeth U, Jorgensen C; ADIPOA Consortium. Adipose Mesenchymal Stromal Cell-Based Therapy for Severe Osteoarthritis of the Knee: A Phase I Dose-Escalation Trial. Stem Cells Transl Med. 2016 Jul;5(7):847-56. doi: 10.5966/sctm.2015-0245. Epub 2016 May 23.
PMID: 27217345BACKGROUND
Biospecimen
blood plasma, synovial fluid
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 13, 2022
First Posted
January 18, 2023
Study Start
April 5, 2022
Primary Completion
April 1, 2023
Study Completion
April 1, 2024
Last Updated
January 18, 2023
Record last verified: 2022-12